Jennifer Rogers, senior analyst at Chilmark — a Boston-based research and advisory firm in the healthcare IT solution market — conducted briefings with 11 vendors for the report. Ms. Rogers also performed a secondary research review to examine prior authorization technology entering the market.
Here are three takeaways from the report.
1. Prior authorization is “on the cusp of having a breakout moment,” Ms. Rogers said. In 2017, Chilmark estimates providers and payers will increasingly see new solutions broadening prior authorization’s role in revenue cycle management, cost containment and population health management.
2. Providers’ growing adoption of value-based care agreements is partially fueling the rise in prior authorization solutions. Technological advances in application programming interfaces, natural language processing and artificial intelligence are also part of the emerging prior authorization model.
3. Ms. Rogers estimates greater provider and payer convergence will feed prior authorization changes as well, and both parties will benefit from new tools and solutions.
To view the report, click here.
More articles on payer issues:
Mission Health board inks op-ed on BCBS feud: 5 things to know
Molina Healthcare to eliminate about 1,400 jobs: 6 things to know
3 analytics strategies to amplify health plan member engagement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
